J. Svartengren

发表

Desensitisation of beta-adrenergic responsiveness in vivo. Decreased coupling between receptors and adenylate cyclase in isolated brown-fat cells.

B. Cannon, P. Svoboda, J. Svartengren, 1982, European journal of biochemistry.

Desensitisation of β-Adrenergic Responsiveness in vivo

P. Svoboda, B. Cannon, J. Svartengren, 2005 .

THE BIOCHEMICAL MECHANISM OF THERMOGENESIS IN BROWN ADIPOSE TISSUE

B. Cannon, J. Nedergaard, U. Sundin, 1978 .

Identification of [3H]prazosin binding sites in crude membranes and isolated cells of brown adipose tissue as alpha 1-adrenergic receptors.

B. Cannon, N. Mohell, J. Svartengren, 1983, European journal of pharmacology.

High number of high-affinity binding sites for (-)-[3H]dihydroalprenolol on isolated hamster brown-fat cells. A study of the beta-adrenergic receptors.

J. Houštěk, B. Cannon, P. Svoboda, 1979, European journal of biochemistry.

The molecular basis for adrenergic desensitization in hamster brown adipose tissue: uncoupling of adenylate cyclase activation.

B. Cannon, P. Svoboda, Z. Drahota, 1984, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

FG5893: A Potential New Generation Anxiolytic/Antidepressant Drug with High Affinity for 5-HT1A and 5-HT2A Receptors

G. Andersson, A. Björk, J. Svartengren, 1996 .

Measurement and Characterization of Energy Intake in the Mouse

R. Mcarthur, J. Svartengren, A. Modiri, 2005, Current protocols in pharmacology.

Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice

J. Janson, T. Andersson, C. Ekholm, 2019, Molecular genetics and metabolism reports.

The functional and structural reorganisation of the plasma membranes of brown adipose tissue induced by cold acclimation of the hamster. I: Changes in catecholamine-sensitive adenylate cyclase activity

J. Naprstek, P. Svoboda, I. Jirmanová, 1984 .

Receptor binding properties of amperozide.

P. Simonsson, J. Svartengren, Per Simonsson, 1990, Pharmacology & toxicology.

Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide.

J. Svartengren, 1993, Journal of receptor research.

Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors.

G. Andersson, A. Björk, T. Klint, 1994, European journal of pharmacology.

Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: Relation to behavioral and clinical effects

A. Björk, E. Pettersson, J. Svartengren, 1997, Biological Psychiatry.

The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.

M. Celander, J. Svartengren, 1994, European journal of pharmacology.